Concepedia

Els O. Witteveen

EO

15

Publications

960

Citations

14

H-Index

1990

Active since

Affiliations

University Medical Center Utrecht(Current)

The Netherlands Cancer Institute

Utrecht University

Slotervaartziekenhuis

Radboud University Nijmegen

Els O. Witteveen is an author at University Medical Center Utrecht specializing in oncology, cancer research, and medicine.

Top concepts

Publications per year

1990–2020

15

Publications

15

A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients

I. E. L. M. Kuppens, Els O. Witteveen, Roxanne C. Jewell et al. · Clinical Cancer Research · 2007 · 174 citations

Pharmacogenetic Screening of CYP3A and ABCB1 in Relation to Population Pharmacokinetics of Docetaxel

Tessa M. Bosch, Alwin D. R. Huitema, Valerie D. Doodeman et al. · Clinical Cancer Research · 2006 · 125 citations

Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study

Kristel Van Calsteren, René Verbesselt, Nelleke Ottevanger et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2010 · 120 citations · Full text

Phase I Clinical Evaluation of Weekly Administration of the Novel Vascular-Targeting Agent, ZD6126, in Patients With Solid Tumors

Laurens V. Beerepoot, Sandra A. Radema, Els O. Witteveen et al. · Journal of Clinical Oncology · 2006 · 114 citations

Late Release of Circulating Endothelial Cells and Endothelial Progenitor Cells after Chemotherapy Predicts Response and Survival in Cancer Patients

Jeanine M.L. Roodhart, Marlies H.G. Langenberg, Joost S.P. Vermaat et al. · Neoplasia · 2010 · 79 citations · Full text

Rows per page

1–5 of 15